Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 39Leukemia 16Congenital Abnormalities 10Leukemia, Monocytic, Acute 8Leukemia, Myelomonocytic, Acute 7Leukemia, Megakaryoblastic, Acute 6Leukemia, Erythroblastic, Acute 6Myelodysplastic Syndromes 5Recurrence 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Eosinophilic, Acute 3Anemia, Refractory, with Excess of Blasts 3Leukemia, Promyelocytic, Acute 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Basophilic, Acute 2Neoplasms 1Myeloproliferative Disorders 1Lymphoma, Non-Hodgkin 1Liver Neoplasms 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Biphenotypic, Acute 1Childhood Acute Promyelocytic Leukemia With PML-RARA 1

Interventions

merphos 1azathiopurine 1arsenous acid 1Tretinoin 1Mitoxantrone 1Methotrexate 1Mercaptopurine 1Idarubicin 1Cytarabine 1Arsenic Trioxide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Childhood Acute Promyelocytic Leukemia With PML-RARA × Idarubicin × Clear all
NCT00866918 2022-10-25

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia

Children's Oncology Group

Phase 3 Completed
106 enrolled 14 charts
MyeloidOther hematologic neoplasm

Childhood Acute Promyelocytic Leukemia With PML-RARA

Data powered by HemOnc (CC BY 4.0) Colophon âš¡